Cronos Group: Raymond James Sees US$4.10/Share Valuation Just For Ginkgos Partnership

Raymond James recently upgraded Cronos Group (TSX: CRON) (NASDAQ: CRON) to an Outperform 2 rating as well as almost doubling their price target to C$13.52 / U$10. The justification behind this was that they believe Cronos’ partnership with Ginkgo Bioworks currently adds $1.54 billion or US$4.10 a share in value. After all, Raymond James has created a valuation method specific to cannabinoid biosynthesis.

Raymond James estimates that the global market for products made by cannabinoid biosynthesis will grow from C$10 billion in 2025 to C$115 billion in 2040 with an estimated EBITDA coming in at C$1.3 billion and C$15.2 billion respectively for the sector. Furthermore, its estimated that the present value for the sector is currently ~C$40 billion as a result. The firm says Cronos will begin to see “material revenues for CRON within 12-18 months” from the Ginkgos partnership as a result, although they do not change their revenue estimates for Cronos, which is U$71.5m in revenue with a gross profit of C$35.6m for FY2020.

This updated outlook from Raymond James is noteworthy because with this upgrade they believe there is a ~60% upside to the stock, the highest out of any analyst. With the mean analyst price target being C$8.60, not only is their price target considerably different from their peers but so is their rating, with the firm having an Outperform 2 rating for Cronos, the highest rating Cronos currently has.

There are 12 analysts currently providing a rating, and Raymond has the only outperform rating while only one other firm has a buy rating. The remainder have holds (7) or strong sells (2).


Information for this briefing was found via Sedar, Raymond James and Cronos Group. The author has no securities or affiliations related to these organizations. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Gold Drilling Scaled to 60,000 Meters: How Big Can This Get? | Roger Rosmus – Goliath Resources

Baselode Energy To Acquire Forum Energy: The Merger Of Equals Deal

TriStar Gold: The Revised Castelo de Sonhos Prefeasibility Study

Recommended

Antimony Resources Drills 4.17% Antimony Over 7.4 Metres At Bald Hill

ESGold To Expand Mine Building At Montauban In Advance Of Gold & Silver Production

Related News

WeedMD: Canaccord Initiates Coverage With $0.60 Price Target

Yesterday morning, Canaccord Genuity initiated coverage on WeedMD Inc (TSXV: WMD) with a C$0.60 12-month...

Thursday, March 25, 2021, 11:47:00 AM

Karora: Haywood Reiterates Ratings After Three Year Guidance Announcement

On June 28th, Karora Resources Inc. (TSX: KRR) announced its three-year production guidance, whereby they...

Wednesday, June 30, 2021, 04:53:00 PM

Canopy Growth: Canaccord Reduces Target To $6, Anticipates Further Cost Cutting

Canopy Growth (TSX: WEED) is expected to report its fiscal fourth-quarter financial results tomorrow morning....

Thursday, May 26, 2022, 04:32:00 PM

Canaccord Initiates On FuelCell Energy With $4.50 Price Target, Hold Rating

On December 9th, Canaccord Genuity initiated coverage on FuelCell Energy (NASDAQ: FCEL) with an $8.50...

Thursday, December 10, 2020, 03:39:00 PM

Nvidia: Analysts Anticipate $5.8 Billion In Q3 Revenues

Nvidia Corp (NASDAQ: NVDA) will be reporting their fiscal third quarter financial results May 26th...

Wednesday, May 26, 2021, 11:44:00 AM